Sell-side reaction to FTD earnings (2Q05 earnings results)
-
Font Size:
Citigroup analyst Mark Mahaney sent a note to clients August 9th analyzing FTD's (ticker: FTD) Q2 earnings. Excerpts:
Not subscribed to The Internet Stock Blog? You can get updated headlines for free by adding The Internet Stock Blog to your My Yahoo page. Just log into your My YahooFTD - Still Not Spring
SUMMARY
FTD reported a Modest Beat & In-Line Quarter -- $123MM revenue was a tad shy of our/Street's $124MM estimate, but $0.18 EPS beat our/Street's $0.15 estimate. FY06 guidance was In-Line with the Street. The EPS upside sources were better than expected gross margins and lower than expected G&A.
Fundies worsened - 1.8% Y/Y rev growth was the lowest in many quarters, although Easter holiday timing played a major factor. Easter-normalized Y/Y growth was approx 9%, a deceleration from prior periods. 13.3% EBITDA margin was down 10 bps Y/Y and down 180 bps Q/Q.
No change in our opinion on the stock. Our FY2006 estimate nudges up from $0.74 to $0.75, but our price target remains $13.
Among the positives - sustainably ramping gross margins and debt paydown. Among the negatives - still rising marketing costs and guidance-implied margin declines in FY06. Marketshare shifts ambiguous.
JUNE BY THE NUMBERS
FTD reported June quarter revenue of $123MM, EBITDA of $16.2MM, and EPS of $0.18, vs. our estimates of $124MM, $14.5MM, and $0.15 EPS, respectively.
The slight revenue miss vs. our expectations was due to underperformance in the Florist segment. Florist revenue came in at $44.6MM, $2.6MM or 6% below our expectation of $47.2MM and down 2.8% Y/Y. Florist results reflected the elimination of unprofitable product lines in the Specialty wholesaling business, as well as Easter holiday timing, which was in the third quarter of fiscal year 2005 vs. the fourth quarter in 2004 (the June quarter is Q4 for FTD). Consumer revenue of $78MM exceeded our estimate of $76.2 by 2%, and was up 4.7% Y/Y, driven by an increase in Mother’s Day orders but partially offset by the timing of the Easter holiday.
Gross margin came in 0.7% higher than we expected (42% vs. 41.3%), in part due to the elimination of the unprofitable product lines discussed above. Florist gross margin was 71.2% vs. our estimate of 69%, while Consumer gross margin of 26.1% exceeded our 25% estimate by 110 bps. Consumer gross margins are benefiting from the increasing shift of order to the Internet (89.3% of total vs. 86.3% Q/Q) and the increasing contribution from higher margin Specialty Gift orders (30.7% vs. 27.6% Q/Q).
Despite the revenue miss, EBITDA came in $1.8MM or 12% better than our expectation with gross margin and G&A being the major variances. G&A was $13.2MM, $1.8MM or 12% lower than our estimate. As a result, EBITDA margins were 13.3%, 1.5% higher than we expected.
page, then go to The Internet Stock Blog and click on the "+ My Yahoo"
button on the top right of your screen. You can do the same for other sites, such as The China Stock Blog, ETF Investor, Radical Guides and Seeking Alpha.
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
-
Editor's Picks
-
Most Popular
- Assurant Is A Compelling Short Sell
- Broadcom Enters FTTH Chipset Market
- Another Macroshares Oil Arbitrage Opportunity
- Freeport McMoran: With Copper Prices Rising, It's Still a Buy
- Oil and the Futures Market
- Three Ways to Cash In on Record Meat and Dairy Prices
- Full list of Editor's Picks »
- High Likelihood of a Market Crash »
- Time To Start Buying Some Dogs? »
- Sirius-XM Combination: A Future Microsoft Acquisition? »
- JP Morgan Offer for Wachovia Makes Sense »
- High-Yield Canadian Royalty Trusts: What's the Catch? »
- Adding to My GE Position »
- 7 Stocks for a High Yield Cash Flow Portfolio »
- Drybulk Shipping: Prepare for a New Record High »
- Nokia: Bargain of a Lifetime - Barron's »
- Top 10 Payout Yield Stocks »
- Wall Street Breakfast: Must-Know News »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- A New Strategy for EXACT Sciences
- Cytori Therapeutics: The Stem Cell 'Celution' for Success
- LDK Solar: The Brightest Opportunity?
- Big Lots, Wal-Mart and Costco: 3 Musketeers of the Pooring of America
- What's Behind Hansen's Smackdown?
- The Long Case for China Medical Technologies
- ASA Limited: A Golden Opportunity
- ValueClick: Has the Hunted Become the Hunter?
- Petrohawk and Chesapeake Fly on Haynesville Shale News
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Full list of Long Ideas »
- Crystal River’s Q2 Write-Downs Could Bankrupt the Company
- Assurant Is A Compelling Short Sell
- Fuel Systems Solutions: Time to Take Profits
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Pair Trade Visa and Capital One
- Amazon's Kindle Numbers: All Fluff, Zero Substance
- A. Schulman: Cashless Profits
- Titan Machinery: Doesn't Anybody Look at Valuation?
- Goodrich Petroleum: Gas in the Ground Doesn't Mean Cash in the Bank
- Outlook Remains Grim for MBIA, Ambac
- Full list of Short Ideas »
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Momentum Stocks Stalled - Cramer's Stop Trading! (7/3/08)
- Expecting a Lift for Pediatrix: Cramer's Mad Money (7/3/08)
- The Most Bullish Thing - Cramer's Stop Trading! (7/1/08)
- Exelon's Got Nukes - Cramer's Lightning Round (7/1/08)
- Prescription Prediction for Allscripts - Cramer's Mad Money (7/1/08)
- Rex Marks the Spot - Cramer's Lightning Round, (6/30/08)
- Medicare Bill Buys - Cramer's Mad Money (6/30/08)
- Cracker Bottom of the Barrel - Cramer's Lightning Round (6/27/08)
- Britannia Bulk Rules the Waves - Cramer's Mad Money (6/27/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email


